70 year old man with prostate cancer was given radiotherapy. The recurrence of the cancer is monitored biochemically by
Ans. (c) Prostate specific antigen onlyRef: Bailey & Love 26th ed. /1341* The most common presentation of advanced prostate cancer is a patient with a rising PSA level in whom initial local therapy has failed. Generally, after a radical prostatectomy, the PSA level should be less than 0.2 ng/ mL and, after radiation therapy, less than 0.5 ng/mL. Other important prognostic indicators include PSA velocity, time to PSA nadir, time to PSA recurrence, and pattern of PSA recurrence.* PSA levels for all men with prostate cancer who are having radical treatment should be checked at the earliest 6 weeks following treatment, at least every 6 months for the first 2 years and then at least once a year thereafter.
Androgens only
Prostate specific antigen and carcino-embryonic antigen
Prostate specific antigen only
ALP and CEA
Prostate Cancer